Unity Biotechnology, Inc. (UBX)

Unity Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8.9	19.8	12.74	32.91	17.81	37.47
Short-Term Investments	20.14	23.4	82.06	55.17	79.89	90.02
Cash & Short-Term Investments	29.04	43.2	94.8	88.08	97.7	127.49
Cash Growth	-36.79%	-54.43%	7.63%	-9.85%	-23.37%	-25.50%
Other Receivables	-	1.58	0.24	-	-	-
Receivables	-	1.58	0.24	-	-	-
Prepaid Expenses	1.23	1.83	1.51	1.88	3.17	2
Restricted Cash	-	-	-	0.55	-	-
Total Current Assets	30.26	46.61	96.54	90.5	100.87	129.49
Property, Plant & Equipment	15.77	18.06	26.87	31.23	36.14	16.64
Long-Term Investments	-	-	-	1.99	17.87	3.03
Other Long-Term Assets	1.1	1.02	0.95	0.99	1.45	2.07
Total Assets	47.13	65.69	124.35	124.71	156.32	151.22
Accounts Payable	1.8	1.38	1.79	1.99	2.56	5.19
Accrued Expenses	3.25	3	5.24	6.01	7.36	8.81
Current Portion of Long-Term Debt	-	-	9.48	4.02	-	-
Current Portion of Leases	3.73	3.45	3.1	4.38	4.52	-
Current Unearned Revenue	-	-	-	0.22	-	-
Other Current Liabilities	-	0.01	0.01	0.01	0.02	3.22
Total Current Liabilities	8.78	7.84	19.62	16.62	14.46	17.22
Long-Term Debt	-	-	10.89	18.41	24.51	-
Long-Term Leases	20.7	23.54	26.99	30.09	34.47	-
Other Long-Term Liabilities	3.51	5.91	10.76	0.02	-	13.3
Total Liabilities	32.99	37.29	68.27	65.14	73.44	30.51
Common Stock	0	0	0	0	0.01	0.01
Additional Paid-In Capital	516.01	512.77	500.83	459.64	422.38	366.7
Retained Earnings	-501.9	-484.35	-444.49	-400.02	-339.3	-245.46
Comprehensive Income & Other	0.04	-0.02	-0.25	-0.04	-0.21	-0.54
Total Common Equity	14.14	28.4	56.08	59.57	82.88	120.71
Shareholders' Equity	14.14	28.4	56.08	59.57	82.88	120.71
Total Liabilities & Equity	47.13	65.69	124.35	124.71	156.32	151.22
Total Debt	24.43	26.99	50.46	56.9	63.5	-
Net Cash (Debt)	4.61	16.21	44.34	33.17	52.07	130.51
Net Cash Growth	-74.61%	-63.44%	33.67%	-36.30%	-60.10%	-23.72%
Net Cash Per Share	0.28	1.10	4.67	5.94	10.24	29.92
Filing Date Shares Outstanding	16.85	16.79	14.34	6.89	5.47	4.76
Total Common Shares Outstanding	16.85	16.78	14.22	6.3	5.33	4.72
Working Capital	21.48	38.77	76.92	73.89	86.4	112.27
Book Value Per Share	0.84	1.69	3.95	9.46	15.56	25.56
Tangible Book Value	14.14	28.4	56.08	59.57	82.88	120.71
Tangible Book Value Per Share	0.84	1.69	3.95	9.46	15.56	25.56
Machinery	-	4.82	5.34	7.04	7.29	6.52
Construction In Progress	-	-	-	0.01	-	-
Leasehold Improvements	-	9.52	15.24	15.16	15.08	16.44

Source: S&P Capital IQ. Standard template. Financial Sources.